首页> 美国卫生研究院文献>British Journal of Cancer >Combined modality management of local and disseminated adult soft tissue sarcomas: a review of 257 cases seen over 10 years at the Christie Hospital Holt Radium Institute Manchester.
【2h】

Combined modality management of local and disseminated adult soft tissue sarcomas: a review of 257 cases seen over 10 years at the Christie Hospital Holt Radium Institute Manchester.

机译:局部和散布的成人软组织肉瘤的联合治疗:在曼彻斯特的克里斯蒂医院和霍尔特镭研究所研究了257例病例历时10年。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Over a 10 year period, between 1974-1984, 257 adult cases of tissue sarcoma have been evaluated in the Department of Medical Oncology, Christie Hospital, Manchester. At registration locally advanced or metastatic diseases was present in 162 (63%). The male/female ratio was 1.5:1 and median age 54 years (range 14-85). The commonest sites were lower limb (33%), visceral (21%), trunk (13%), retroperitoneum (12%) and upper limb (10%). Leiomyosarcoma (27%), liposarcoma (14%) malignant fibrous histiocytoma (10%) and neuro plus fibrosarcomas (15%) were the most frequent histological subtypes. A high proportion of uterine sarcomas (17%) is a point of distinction from many other series. Histological grade was specified in 72% of cases and the distribution (Grade I--27%; II--6%; III--67%) reflected a referral bias towards advanced disease. Local resection of the primary tumour was performed in 76% of cases. In many instances this only amounted to 'shelling out' and true compartmental excisions were rare. Amputation was performed in 31% of patients with limb sarcomas. Ninety-eight patients (38%) had experienced one or more local recurrences prior to referral and the overall local recurrence rate was 56%. Suitable patients (78%) received chemotherapy, 50% entering multicentre trials in collaboration with the EORTC. The commonest regime used in patients with advanced disease was CYVADIC which produced an overall response rate of 37%. Ifosfamide, used as a single agent in 16 patients, induced 3CR and 5PR for an overall response rate of 50%. When used in combination with MTX and VADIC, there was no difference in response rate, but numbers in these pilot studies were small. Seventeen high risk patients received adjuvant chemotherapy with VAC, but the results (11 relapses) were disappointing. An EORTC trial, comparing adjuvant CYVADIC chemotherapy with control has accrued 307 patients, 49 of these from the Christie Hospital. Preliminary results within this centre - 13/25 relapses in the control arm, 5/23 in the chemotherapy arm-suggest an advantage for chemotherapy but the data are statistically not significant. Post-operative radical radiotherapy after resection of the primary tumour or local recurrence was performed in 51 patients, with local control in 65% of cases, although metastases developed in 41%. At the time of analysis (1st April 1984) 98 (38%) were alive, of whom 72 showed no evidence of disease and 52 had never relapsed. Malignant disease was the cause of death in 92%. Overall survival was not influenced by sex, but patients less than 40 years of age fared significantly better (P less than 0.001).(ABSTRACT TRUNCATED AT 400 WORDS)
机译:在1974年至1984年的10年中,曼彻斯特克里斯蒂医院医学肿瘤科评估了257例成人组织肉瘤。登记时,当地有162例(63%)存在晚期或转移性疾病。男女比例为1.5:1,中位年龄为54岁(范围14-85)。最常见的部位是下肢(33%),内脏(21%),躯干(13%),腹膜后(12%)和上肢(10%)。平滑肌肉肉瘤(27%),脂肪肉瘤(14%),恶性纤维组织细胞瘤(10%)和神经加纤维肉瘤(15%)是最常见的组织学亚型。高比例的子宫肉瘤(17%)是许多其他系列的区别点。在72%的病例中指定了组织学等级,其分布(I--27%; II-6%; III--67%)反映了对晚期疾病的转诊偏见。 76%的病例进行了原发肿瘤的局部切除。在许多情况下,这仅相当于“炮击”,真正的隔室切除很少。 31%的肢体肉瘤患者进行了截肢术。 98名患者(38%)在转诊之前经历了一次或多次局部复发,总体局部复发率为56%。合适的患者(78%)接受了化疗,其中50%与EORTC一起参加了多中心试验。晚期患者中最常用的治疗方案是CYVADIC,其总缓解率为37%。异环磷酰胺作为单药用于16例患者,可诱导3CR和5PR,总缓解率为50%。与MTX和VADIC组合使用时,应答率没有差异,但这些先导研究的数字很小。 17名高危患者接受了VAC辅助化疗,但结果(11次复发)令人失望。一项EORTC试验将CYVADIC辅助化疗与对照进行了比较,共招募了307位患者,其中49位来自佳士得医院。在该中心内的初步结果-对照组复发13/25,化疗组复发5/23-这对于化疗是有利的,但统计上没有统计学意义。切除原发肿瘤或局部复发的术后根治性放疗有51例,局部控制在65%的病例中,尽管有41%发生了转移。在分析时(1984年4月1日),有98位(38%)还活着,其中72位未显示出疾病迹象,而52位从未复发。恶性疾病是92%的死亡原因。总体存活率不受性别影响,但年龄小于40岁的患者的病情明显好转(P小于0.001)。(摘要截断为400字)

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号